| Dr Thomas Joseph Perry, MD | |
|
9139 Ridgeline Blvd, Highlands Ranch, CO 80129-2333 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Dr Thomas Joseph Perry |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 9139 Ridgeline Blvd, Highlands Ranch, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598177651 | NPI | - | NPPES |
| 029085 | Other | CO | KAISER COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | R4618 (Texas) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | DR.0064899 (Colorado) | Primary |
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
A latest US study shows that more people are suffering serious injury or death while wearing headphones. The number has tripled in six years.
A new clinical study at the University of Michigan Health System will test the ability of a once daily dose of doxycycline to reduce the growth of small abdominal aortic aneurysms.
More than 20 million people in the U.S., and many more worldwide, who have been exposed to asbestos are at risk of developing mesothelioma, a malignant cancer of the membranes that cover the lungs and abdomen that is resistant to current therapies.
When trying to inform their decisions on behavioral health policy, almost three-quarters of state legislators choose not to use universities, where most research is undertaken, as a primary source.
Access Pharmaceuticals, Inc., today announced it has initiated a Phase I/II dose-escalating study of its proprietary, anti-cancer drug, Thiarabine, a nucleoside analog for patients with hematologic malignancies (cancers of the blood). The primary objective of the study is to determine the maximum tolerated dose (MTD) in two different dosing schedules with various leukemias and lymphomas and recommended Phase II dose. The program is being led by Hagop Kantarjian, M.D., Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Joseph Perry, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: () - | Dr Thomas Joseph Perry, MD 9139 Ridgeline Blvd, Highlands Ranch, CO 80129-2333 Ph: (303) 338-4545 |
News Archive
A latest US study shows that more people are suffering serious injury or death while wearing headphones. The number has tripled in six years.
A new clinical study at the University of Michigan Health System will test the ability of a once daily dose of doxycycline to reduce the growth of small abdominal aortic aneurysms.
More than 20 million people in the U.S., and many more worldwide, who have been exposed to asbestos are at risk of developing mesothelioma, a malignant cancer of the membranes that cover the lungs and abdomen that is resistant to current therapies.
When trying to inform their decisions on behavioral health policy, almost three-quarters of state legislators choose not to use universities, where most research is undertaken, as a primary source.
Access Pharmaceuticals, Inc., today announced it has initiated a Phase I/II dose-escalating study of its proprietary, anti-cancer drug, Thiarabine, a nucleoside analog for patients with hematologic malignancies (cancers of the blood). The primary objective of the study is to determine the maximum tolerated dose (MTD) in two different dosing schedules with various leukemias and lymphomas and recommended Phase II dose. The program is being led by Hagop Kantarjian, M.D., Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas.
› Verified 7 days ago
Kendra Poarch, PA Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9137 Ridgeline Blvd Ste 145, Highlands Ranch, CO 80129 Phone: 303-800-6093 | |
Dr. Walter Korea Lee, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9139 Ridgeline Blvd, Highlands Ranch, CO 80129 Phone: 303-338-4545 | |
Dr. Jon P Carlson, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9139 Ridgeline Blvd, Highlands Ranch, CO 80129 Phone: 303-338-4545 | |
Dr. Erin Elizabeth O'flaherty, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9139 Ridgeline Blvd, Highlands Ranch, CO 80129 Phone: 303-338-4545 | |
Dr. Alice Jean Major, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9139 Ridgeline Blvd, Highlands Ranch, CO 80129 Phone: 303-338-4545 | |
Dr. Mark W Rhine, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9139 S. Ridgeline Blvd, Suite 210, Highlands Ranch, CO 80129 Phone: 303-338-4545 | |
Dr. William Rodriguez Cartagena, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9139 Ridgeline Blvd, Highlands Ranch, CO 80129 Phone: 303-338-4545 |